Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:gamma-Glutamyl-Se-methylselenocysteine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000509 AN000780 Metabolic changes to maternal rat liver tissue during and post-pregnancy Liver Rat University of Colorado, Denver Arbitrary units
ST000510 AN000782 Assessing metabolic changes to maternal rat liver tissue during and post-pregnancy (part II) Liver Mouse University of Colorado, Denver Arbitrary units
ST001788 AN002899 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University Intensity
ST002200 AN003600 Human Trisome Project Plasma Metabolomics v1 Blood Human Down syndrome University of Colorado Denver peak area
ST002213 AN003619 Metabolic changes in Alzheimer patient-derived induced neurons versus non-demented controls Fibroblast cells Human Alzheimers disease University of Colorado Denver peak area
ST002213 AN003621 Metabolic changes in Alzheimer patient-derived induced neurons versus non-demented controls Fibroblast cells Human Alzheimers disease University of Colorado Denver peak area
ST002214 AN003623 The effects of PKM2 modulation and hypoxia on the metabolic landscape of Alzheimer patient-derived induced neurons Fibroblast cells Human Alzheimers disease University of Colorado Denver peak area
ST002485 AN004057 Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis - mouse serum metabolomics Blood Mouse Cancer University of Colorado Denver peak area
ST001736 AN002826 The COVIDome Explorer Researcher Portal (blood plasma) Blood Human COVID-19 University of Colorado Anschutz Medical Campus Peak area
ST002857 AN004679 Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human CSF and Serum Cerebrospinal fluid Human Multiple sclerosis University of Colorado Peak area
ST002858 AN004684 Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human Serum Blood Human Multiple sclerosis University of Colorado Anschutz Medical Campus Peak area
ST002034 AN003307 Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Feces-part2) Feces Mouse University of Colorado Anschutz Medical Campus peak area top
ST002036 AN003311 Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Kidney) Kidney Mouse University of Colorado Anschutz Medical Campus peak area top
ST002038 AN003315 Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Duodenum) Duodenum Mouse University of Colorado Anschutz Medical Campus peak area top
ST002040 AN003319 Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Colon) Colon Mouse University of Colorado Anschutz School of Medicine peak area top
ST002066 AN003365 Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer Lung Mouse Cancer The Walter and Eliza Hall Institute of Medical Research peak height
ST002792 AN004542 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University peak height
ST002926 AN004798 Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression Blood Plasmodium falciparum Malaria Monash University peak height
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000414 AN000655 Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000546 AN000832 Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST001033 AN001694 Determination of mode of action of anti-malalrial drugs using untargeted metabolomics Cultured cells Plasmodium falciparum Malaria Monash University Peak height
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001549 AN002580 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University Peak intensity
ST001242 AN002063 Global Metabolic Analysis Trisomy 21 - Cohort 3, CSF Cerebrospinal fluid Human Down syndrome University of Colorado, Denver Relative Abundance
ST002109 AN003451 Towards a mechanistic understanding of patient response to neoadjuvant SBRT with anti-PDL1 in human HPV-unrelated locally advanced HNSCC: Phase I/Ib trial results (Part 1) Blood Human Cancer University of Colorado Denver Relative Abundance
ST002110 AN003453 Towards a mechanistic understanding of patient response to neoadjuvant SBRT with anti-PDL1 in human HPV-unrelated locally advanced HNSCC: Phase I/Ib trial results (Part 2) Blood Human Cancer University of Colorado Denver Relative Abundance
ST002107 AN003446 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST002108 AN003448 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST001175 AN001950 Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria Monash University Signal Intensity
ST001304 AN002172 Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii Fibroblast cells Toxoplasma gondii Parasitic infection Monash University Signal Intensity
  logo